(Neuro Kinetics, Inc.) Among three new US patents awarded to Neuro Kinetics is protection for its I-PAS design, a highly portable device for oculomotor testing using clinically sensitive eye tracking. Looking similar to a virtual reality headset, the I-PAS is just as easy to put on. After years of I-PAS use for clinical investigations, FDA clearance is now pending for commercial use as a nystamograph. Concussion-related testing will still be investigational. NKI’s patent count now reaches 22.